Skip to product information
Palbociclib 125mg – LuciPalbo
KSh28,000.00
|
What it treats: |
Palbociclib is an oral cyclin-dependent kinase (CDK) 4/6 inhibitor used in breast cancer treatment. |
|
Breast Cancer |
Hormone Receptor (HR)-Positive, HER2-Negative Advanced or Metastatic Breast Cancer In combination with an aromatase inhibitor (e.g., letrozole) as initial endocrine-based therapy in postmenopausal women or men. In combination with fulvestrant in patients with disease progression after prior endocrine therapy. |